Evidence map›Paper›PMID 41764692›Full record

ArticleMolecular diversity2026

Enhancing ADMET property predictions using cross-aligned multimodal attention mechanisms.

Xinkang Li, Yilin Ye, Ran Xu, Fangfang Jiao, Ziping Hu, Henry H Y Tong, Liangzhen Zheng, Jingjing Guo

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular diversity, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Xinkang LiCentre in Artificial Intelligence Driven Drug Discovery, Faculty of Applied Sciences, Macao Polytechnic University, Macao, China.
Yilin YeCentre in Artificial Intelligence Driven Drug Discovery, Faculty of Applied Sciences, Macao Polytechnic University, Macao, China.
Ran XuCentre in Artificial Intelligence Driven Drug Discovery, Faculty of Applied Sciences, Macao Polytechnic University, Macao, China.
Fangfang JiaoCentre in Artificial Intelligence Driven Drug Discovery, Faculty of Applied Sciences, Macao Polytechnic University, Macao, China.
Ziping HuJiangmen Industrial Technology Research Institute of Guangdong Academy of Sciences Ltd., Jiangmen, China.
Henry H Y TongCentre in Artificial Intelligence Driven Drug Discovery, Faculty of Applied Sciences, Macao Polytechnic University, Macao, China.
Liangzhen ZhengShenzhen Zelixir Biotech Company Ltd., Shenzhen, China. zhenglz@zelixir.com.
Jingjing GuoCentre in Artificial Intelligence Driven Drug Discovery, Faculty of Applied Sciences, Macao Polytechnic University, Macao, China.

Funding

Macao Polytechnic University RP/CAI-01/2022
6 · The paper itself

Abstract

Accurate prediction of drug metabolism and pharmacokinetics (ADMET) properties is crucial in drug discovery. Here, we present a novel approach to enhance ADMET property predictions using Cross-Aligned Multimodal Attention (CMA) mechanisms, pretrained models, and multimodal techniques. ADMET data is collected and processed using image processing, graph neural networks, and chemical fingerprinting. Pretrained models like GROVER and ResNet generate a multi-channel data format, and the CMA mechanism aligns and correlates the data modalities. Grad-CAM technology interprets the model's predictions, visually demonstrating the relationship between compound properties and fragments. Our ADMET property prediction server ( http://guolab.mpu.edu.mo/CMA ) implements the CMA-based model and a substantial language model for ADMET property prediction. The innovation lies in the integration of multimodal data, the application of pretrained models, and the development of cross-modal alignment. This approach improves the efficiency and accuracy of ADMET property predictions and opens new avenues for research in molecular science, particularly in drug design and evaluation.

Indexed as

Drug DiscoveryPharmacokineticsGraph Neural NetworksPharmaceutical PreparationsPrediction AlgorithmsPharmaceutical PreparationsADMETAttention mechanismGrad-CAMGraph neural networksMolecular property predictionMultimodal techniques

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.